JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB50011

Anti-Erk1 (pT202/pY204) + Erk2 (pT185/pY187) antibody [MAPK-YT]

4

(14 Reviews)

|

(146 Publications)

Mouse Monoclonal ERK2 antibody. Suitable for ICC/IF, WB and reacts with Rat, Drosophila melanogaster, Saccharomyces cerevisiae samples. Cited in 146 publications. Immunogen corresponding to Synthetic Peptide within Human MAPK3 phospho T202 + Y204 conjugated to Keyhole Limpet Haemocyanin.

View Alternative Names

ERK2, PRKM1, PRKM2, MAPK1, Mitogen-activated protein kinase 1, MAP kinase 1, MAPK 1, ERT1, Extracellular signal-regulated kinase 2, MAP kinase isoform p42, Mitogen-activated protein kinase 2, ERK-2, p42-MAPK, MAP kinase 2, MAPK 2

3 Images
Immunocytochemistry/ Immunofluorescence - Anti-Erk1 (pT202/pY204) + Erk2 (pT185/pY187) antibody [MAPK-YT] (AB50011)
  • ICC/IF

Supplier Data

Immunocytochemistry/ Immunofluorescence - Anti-Erk1 (pT202/pY204) + Erk2 (pT185/pY187) antibody [MAPK-YT] (AB50011)

ICC/IF of NRK cells labeling the activated form of MAP kinase with ab50011 (1/1000 dilution). The antibody was developed using Goat Anti-Mouse IgG, Cy3™ conjugate. Cells were counterstained with DAPI (blue).

Immunocytochemistry/ Immunofluorescence - Anti-Erk1 (pT202/pY204) + Erk2 (pT185/pY187) antibody [MAPK-YT] (AB50011)
  • ICC/IF

Unknown

Immunocytochemistry/ Immunofluorescence - Anti-Erk1 (pT202/pY204) + Erk2 (pT185/pY187) antibody [MAPK-YT] (AB50011)

In situ immunostaining of the activated form of MAP kinase with ab50011 (green) in Drosophila wing imaginal disc (500 micrometers long).

Western blot - Anti-Erk1 (pT202/pY204) + Erk2 (pT185/pY187) antibody [MAPK-YT] (AB50011)
  • WB

Unknown

Western blot - Anti-Erk1 (pT202/pY204) + Erk2 (pT185/pY187) antibody [MAPK-YT] (AB50011)

Lane 1:

Western blot - Anti-Erk1 (pT202/pY204) + Erk2 (pT185/pY187) antibody [MAPK-YT] (ab50011) at 1/10000 dilution

Lane 2:

no primary antibody

All lanes:

Extract of Rat1 cells activated with 100µM Vanadate+200µM H<sub>2</sub>O<sub>2</sub>

Secondary

All lanes:

Goat Anti-Mouse IgG, AlkPhos Conjugate

Predicted band size: 44 kDa

Observed band size: 42 kDa,44 kDa

false

Key facts

Host species

Mouse

Clonality

Monoclonal

Clone number

MAPK-YT

Isotype

IgG1

Carrier free

No

Reacts with

Rat, Saccharomyces cerevisiae, Drosophila melanogaster

Applications

ICC/IF, WB

applications

Immunogen

Synthetic Peptide within Human MAPK3 phospho T202 + Y204 conjugated to Keyhole Limpet Haemocyanin. The exact immunogen used to generate this antibody is proprietary information.

P27361

Epitope

The epitope recognized by ab50011 is located in the region of phosphorylated threonine and tyrosine residues within the regulatory site of active MAP kinase (Thr185 and Tyr187 in ERK-2).

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "ICCIF" : {"fullname" : "Immunocytochemistry/ Immunofluorescence", "shortname":"ICC/IF"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Rat": { "ICCIF-species-checked": "testedAndGuaranteed", "ICCIF-species-dilution-info": "1/200", "ICCIF-species-notes": "<p></p>", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/10000", "WB-species-notes": "<p></p>" }, "Drosophila melanogaster": { "ICCIF-species-checked": "testedAndGuaranteed", "ICCIF-species-dilution-info": "1/200", "ICCIF-species-notes": "<p></p>", "WB-species-checked": "guaranteed", "WB-species-dilution-info": "", "WB-species-notes": "" }, "Saccharomyces cerevisiae": { "ICCIF-species-checked": "guaranteed", "ICCIF-species-dilution-info": "1/200", "ICCIF-species-notes": "<p></p>", "WB-species-checked": "guaranteed", "WB-species-dilution-info": "1/10000", "WB-species-notes": "<p></p>" }, "Xenopus laevis": { "ICCIF-species-checked": "predicted", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "", "WB-species-checked": "predicted", "WB-species-dilution-info": "", "WB-species-notes": "" }, "Zebrafish": { "ICCIF-species-checked": "predicted", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "", "WB-species-checked": "predicted", "WB-species-dilution-info": "", "WB-species-notes": "" } } }

Product details

This product was changed from ascites to tissue culture supernatant on 25th October 2016. The following lot is from ascites and is still in stock as of 25th October 2016- GR185138. Lot numbers higher than GR185138 will be from tissue culture supernatant. Please note that the dilutions may need to be adjusted accordingly.

Properties and storage information

Form
Liquid
Purification technique
Proprietary technique
Purification notes
Purified from tissue culture supernatant.
Storage buffer
pH: 7.4 Preservative: 0.097% Sodium azide Constituents: PBS
Shipped at conditions
Blue Ice
Appropriate short-term storage duration
1-2 weeks
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

Erk1 and Erk2 also known as MAPK3 and MAPK1 are part of the mitogen-activated protein kinase family. These proteins play an important role in signal transduction. Erk1 has a mass of about 44 kDa while Erk2 is slightly smaller at approximately 42 kDa. Both proteins are widely expressed in a variety of tissues contributing to the transmission of signals from the cell surface to the DNA in the cell nucleus. Specifically Erk1 and Erk2 are activated through dual phosphorylation at threonine 202 and tyrosine 204 for Erk1 and threonine 185 and tyrosine 187 for Erk2.
Biological function summary

Erk1 and Erk2 are involved in several essential cellular processes including proliferation differentiation and survival. They often operate as part of a larger complex engaging with other proteins to drive cellular responses. Upon activation they move from the cytoplasm to the nucleus where they regulate the activity of various transcription factors. Erk signaling can adjust gene expression by phosphorylating nuclear targets which influences cell cycle progression and apoptosis.

Pathways

Both Erk1 and Erk2 mainly operate within the MAPK/ERK pathway. This signaling pathway is important for transmitting signals from growth factors and other extracellular stimulants. Related proteins such as Ras and Raf are upstream activators in the pathway. Downstream Erk proteins can impact other cascades including those governing cellular growth and division. By interacting with multiple proteins within these pathways Erk1 and Erk2 ensure accurate cellular responses to environmental changes.

Alterations in the function of Erk1 and Erk2 can contribute to cancer development such as colorectal cancer and melanoma. Misregulation of Erk signaling can lead to uncontrolled cell proliferation and tumor growth. These proteins also connect to neurodegenerative disorders like Alzheimer's disease where disrupted Erk signaling may contribute to neuronal damage. Erk1 and Erk2 interact with other disease-related proteins like BRAF in cancer and APP in Alzheimer's highlighting their role in disease pathophysiology.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Serine/threonine kinase which acts as an essential component of the MAP kinase signal transduction pathway. MAPK1/ERK2 and MAPK3/ERK1 are the 2 MAPKs which play an important role in the MAPK/ERK cascade. They participate also in a signaling cascade initiated by activated KIT and KITLG/SCF. Depending on the cellular context, the MAPK/ERK cascade mediates diverse biological functions such as cell growth, adhesion, survival and differentiation through the regulation of transcription, translation, cytoskeletal rearrangements. The MAPK/ERK cascade also plays a role in initiation and regulation of meiosis, mitosis, and postmitotic functions in differentiated cells by phosphorylating a number of transcription factors. About 160 substrates have already been discovered for ERKs. Many of these substrates are localized in the nucleus, and seem to participate in the regulation of transcription upon stimulation. However, other substrates are found in the cytosol as well as in other cellular organelles, and those are responsible for processes such as translation, mitosis and apoptosis. Moreover, the MAPK/ERK cascade is also involved in the regulation of the endosomal dynamics, including lysosome processing and endosome cycling through the perinuclear recycling compartment (PNRC); as well as in the fragmentation of the Golgi apparatus during mitosis. The substrates include transcription factors (such as ATF2, BCL6, ELK1, ERF, FOS, HSF4 or SPZ1), cytoskeletal elements (such as CANX, CTTN, GJA1, MAP2, MAPT, PXN, SORBS3 or STMN1), regulators of apoptosis (such as BAD, BTG2, CASP9, DAPK1, IER3, MCL1 or PPARG), regulators of translation (such as EIF4EBP1 and FXR1) and a variety of other signaling-related molecules (like ARHGEF2, DCC, FRS2 or GRB10). Protein kinases (such as RAF1, RPS6KA1/RSK1, RPS6KA3/RSK2, RPS6KA2/RSK3, RPS6KA6/RSK4, SYK, MKNK1/MNK1, MKNK2/MNK2, RPS6KA5/MSK1, RPS6KA4/MSK2, MAPKAPK3 or MAPKAPK5) and phosphatases (such as DUSP1, DUSP4, DUSP6 or DUSP16) are other substrates which enable the propagation the MAPK/ERK signal to additional cytosolic and nuclear targets, thereby extending the specificity of the cascade. Mediates phosphorylation of TPR in response to EGF stimulation. May play a role in the spindle assembly checkpoint. Phosphorylates PML and promotes its interaction with PIN1, leading to PML degradation. Phosphorylates CDK2AP2 (By similarity).. Acts as a transcriptional repressor. Binds to a [GC]AAA[GC] consensus sequence. Repress the expression of interferon gamma-induced genes. Seems to bind to the promoter of CCL5, DMP1, IFIH1, IFITM1, IRF7, IRF9, LAMP3, OAS1, OAS2, OAS3 and STAT1. Transcriptional activity is independent of kinase activity.
See full target information MAPK1

Publications (146)

Recent publications for all applications. Explore the full list and refine your search

Cancer cell international 25:315 PubMed40859234

2025

AZD5153 enhances the chemo-sensitivity of gemcitabine on pancreatic cancer cells in vitro and in vivo.

Applications

Unspecified application

Species

Unspecified reactive species

Haixin Zhu,Minmin Shen,Yiqian Zhu,Ruoqi Wang,Rong Dong,Yuyu Huang,Lulin Zhu,Ying Li,Youyou Yan,Jiang Lou,Bo Zhang,Nengming Lin,Biqin Tan

Advanced science (Weinheim, Baden-Wurttemberg, Germany) 12:e2412520 PubMed40103284

2025

The Super Enhancer-Driven Long Noncoding RNA PRKCQ-AS1 Promotes Neuroblastoma Tumorigenesis by Interacting With MSI2 Protein and Is Targetable by Small Molecule Compounds.

Applications

Unspecified application

Species

Unspecified reactive species

Sujanna Mondal,Pei Y Liu,Janith Seneviratne,Antoine De Weck,Pooja Venkat,Chelsea Mayoh,Jing Wu,Jesper Maag,Jingwei Chen,Matthew Wong,Nenad Bartonicek,Poh Khoo,Lei Jin,Louise E Ludlow,David S Ziegler,Toby Trahair,Pieter Mestdagh,Belamy B Cheung,Jinyan Li,Marcel E Dinger,Ian Street,Xu D Zhang,Glenn M Marshall,Tao Liu

Iranian journal of basic medical sciences 27:685-694 PubMed38645489

2024

Quercetin of huoxuehuayu tongluo decoction and azithromycin combination therapy effectively improves rat tubal factor infertility by inhibiting inflammation.

Applications

Unspecified application

Species

Unspecified reactive species

Liang Shao,Nansu Wang,Yan Yan,Yali Tan,Qin Wu,Lei Lei,Mingming Wang,Ling Liu

Science advances 10:eadk9484 PubMed38507477

2024

Termination of convulsion seizures by destabilizing and perturbing seizure memory engrams.

Applications

Unspecified application

Species

Unspecified reactive species

Shirong Lai,Libo Zhang,Xinyu Tu,Xinyue Ma,Yujing Song,Kexin Cao,Miaomiao Li,Jihong Meng,Yiqiang Shi,Qing Wu,Chen Yang,Zifan Lan,Chunyue Geoffrey Lau,Jie Shi,Weining Ma,Shaoyi Li,Yan-Xue Xue,Zhuo Huang

Science advances 10:eadk8331 PubMed38507478

2024

ERK-activated CK-2 triggers blastema formation during appendage regeneration.

Applications

Unspecified application

Species

Unspecified reactive species

Xiao-Shuai Zhang,Lin Wei,Wei Zhang,Fei-Xue Zhang,Lin Li,Liang Li,Yejie Wen,Jia-Hui Zhang,Suning Liu,Dongwei Yuan,Yanmei Liu,Chonghua Ren,Sheng Li

The Journal of biological chemistry 300:105591 PubMed38141769

2023

LncNFYB promotes the proliferation of rheumatoid arthritis fibroblast-like synoviocytes via LncNFYB/ANXA2/ERK1/2 axis.

Applications

Unspecified application

Species

Unspecified reactive species

Shibai Xiao,Qingqing Ouyang,Yi Feng,Xiaoxi Lu,Yipeng Han,Hao Ren,Qin Huang,Jinjun Zhao,Changhong Xiao,Min Yang

Molecular therapy. Nucleic acids 31:421-436 PubMed36845338

2023

Hypoxia-induced downregulation of microRNA-186-5p in endothelial cells promotes non-small cell lung cancer angiogenesis by upregulating protein kinase C alpha.

Applications

Unspecified application

Species

Unspecified reactive species

Vivien Becker,Xu Yuan,Anne S Boewe,Emmanuel Ampofo,Elke Ebert,Johannes Hohneck,Rainer M Bohle,Eckart Meese,Yingjun Zhao,Michael D Menger,Matthias W Laschke,Yuan Gu

The Journal of neuroscience : the official journal of the Society for Neuroscience 43:1089-1110 PubMed36599680

2023

Convergent Energy State-Dependent Antagonistic Signaling by Cocaine- and Amphetamine-Regulated Transcript (CART) and Neuropeptide Y (NPY) Modulates the Plasticity of Forebrain Neurons to Regulate Feeding in Zebrafish.

Applications

Unspecified application

Species

Unspecified reactive species

Devika S Bodas,Aditi Maduskar,Tarun Kaniganti,Debia Wakhloo,Akilandeswari Balasubramanian,Nishikant Subhedar,Aurnab Ghose

International journal of oral science 14:50 PubMed36257937

2022

Disrupted tenogenesis in masseter as a potential cause of micrognathia.

Applications

Unspecified application

Species

Unspecified reactive species

Chao Liu,Nan Zhou,Nan Li,Tian Xu,Xiaoyan Chen,Hailing Zhou,Ailun Xie,Han Liu,Lei Zhu,Songlin Wang,Jing Xiao

Cancers 14: PubMed35884601

2022

Brassinin Promotes the Degradation of Tie2 and FGFR1 in Endothelial Cells and Inhibits Triple-Negative Breast Cancer Angiogenesis.

Applications

Unspecified application

Species

Unspecified reactive species

Yuan Gu,Vivien Becker,Moqin Qiu,Tianci Tang,Emmanuel Ampofo,Michael D Menger,Matthias W Laschke
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com